True. Although if you were a BP, you would be looking at 2591 over Trofinetide - it has the better safety and efficacy profile.
- Forums
- ASX - By Stock
- NEU
- 2025 M & A Outlook
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.33%
!
$16.54

2025 M & A Outlook, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.54 |
Change
0.055(0.33%) |
Mkt cap ! $2.080B |
Open | High | Low | Value | Volume |
$16.48 | $16.77 | $16.28 | $2.137M | 129.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 267 | $16.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.54 | 48 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 21 | 16.530 |
10 | 491 | 16.520 |
7 | 1663 | 16.510 |
5 | 520 | 16.500 |
6 | 989 | 16.490 |
Price($) | Vol. | No. |
---|---|---|
16.540 | 27 | 4 |
16.550 | 114 | 4 |
16.560 | 553 | 6 |
16.570 | 1154 | 10 |
16.580 | 2038 | 19 |
Last trade - 14.53pm 28/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online